Genzyme Corporation’s patent infringement suit against Eagle
Pharmaceuticals, Inc., remains pending in the U.S. District Court
for the District of Delaware.
In March 2009, the company received notice that Eagle had…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.